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Introduction
In our current health-care systems it becomes more and more important to show that our interventions 
are effective and, often just as important, cost-effective. Clinicians are required to use evidence-based 
treatment protocols and researchers are encouraged to study the clinical- and cost-effectiveness of 
treatment. Policy makers and management need to make decisions about which forms of care to offer 
in a society where health-care costs are growing and budgets are shrinking. A distinction can be made 
between effectiveness (does the treatment work, how does it work, for whom does it work), efficacy 
(does it help) and efficiency (cost-benefit ratio). From a patient perspective, efficacy is the most relevant.
In this chapter a basic scheme for planning and evaluating neuropsychological treatment as 
proposed by Wilson, Herbert and Shiel (2003) is presented. In this approach 11 steps are outlined, 
from specifying the behaviour to be changed to planning for generalisation of treatment results.
In addition, different forms of treatment evidence in general are discussed from single case studies 
to group designs and ultimately the randomised controlled trial (RCT). Special attention is be given 
to the single case experimental design (SCED), which offers a valuable alternative when it is not 
possible to conduct large-scale group studies. Quality standards for reporting the results of RCTs and 
SCEDs are discussed. Finally, an overview of the basics of economic evaluation studies is presented. 
Application of general information on evidence-based medicine (EBM) to neuropsychological 
rehabilitation in particular is done for every topic and illustrated with examples.
Planning and evaluating treatment
One of the key elements of good clinical practice is to make our clinical actions explicit. This is not 
only important for the clinician, but also for the other members of the treatment team. Moreover, it 
is of great importance to the patients and their caregivers. Evaluating individual treatments provides 
information on the efficacy. Finally, it is a way of showing management and policy makers whether 
your treatment is effective. Making your clinical actions explicit will improve communication 
among the different parties involved and will help multidisciplinary and interdisciplinary treatment 
because goals are shared and the frame of reference is known to all. One of the ways to do this is by 
planning and evaluating the treatment of the individual patient in a treatment plan. Wilson et al. 
(2003) proposed an 11-step basic plan for treatment, as outlined in Table 2.1.
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Table 2.1 Setting up a treatment plan
Step Action Example
1 Specify the behaviour to be 
changed
Poor concentration 
2 Decide whether or not an 
operational definition is needed
Unable to stick to a task for more than 3 minutes
3 State the goals or aims of 
treatment
To stick to a task for 3 minutes, 2 times a day, for 5 consecutive 
days; for instance, tooth brushing
4 Measure the problem (take a 
baseline)
Develop a rating scale for nurses to rate attentional behaviour during 
tooth brushing
5 Consider motivators or 
reinforcers
Use specific and positive feedback and praise
Avoid multitasking
6 Plan the treatment Who, when, where, how often, which strategies, etc.
7 Begin treatment Inform patient, caregivers and treatment team when the treatment 
begins
8 Monitor treatment progress Regular measurement of the problem, for instance use the rating 
scale (step 4) every day and evaluate weekly
9 Evaluate treatment Regular evaluations are discussed within the team and compared to 
monitor progress
10 Change if necessary Goals in step 3 may have been too ambitious, change goals to a 
more realistic aim
Or goals are met and new goals need to be set
11 Plan for generalisation How can concentration be improved during other tasks besides 
tooth brushing?
Evidence-based medicine
Evidence-based medicine (EBM) is ‘an approach to caring for patients that involves the explicit and 
judicious use of the clinical research literature combined with an understanding of pathophysiology, 
clinical experience, and patient preferences to aid in clinical decision making’ (EBM Working 
Group, 1992). Although EBM was designed in the field of medicine, the principles and practice can 
easily be applied to neuropsychological rehabilitation. EBM is designed to make treatment decisions 
less biased to preferences or expertise of professionals. Additionally, the application of EBM processes 
helps to ensure that the most effective form of care is offered on the basis of arguments and 
responsibility, as supported by scientific evidence. The term was originally used for an educational 
method of the McMaster Medical School in Canada in which physicians were taught to improve 
their decisions for individual patients.
Applying EBM in clinical practice is done via a five-step method (Schouten, Offringa and 
Assendelft, 2014):
1 Translate the clinical problem into an answerable question.
2 Search efficiently for the best evidence.
3 Assess the evidence in terms of methodological quality and applicability in your own clinical 
situation.
4 Make a decision on the basis of the evidence.
5 Evaluate the quality of this process on a regular basis.
The amount of evidence in medicine (nowadays) is overwhelming and it needs to be gathered and 






Figure 2.1 Process of clinical decision-making.
This way, clinicians can use the best and most up-to-date evidence for decisions about individual 
patients. In the definition of EBM the clinician is supposed to use the evidence ‘carefully, explicitly 
and judiciously’. In addition to the best evidence, the clinician will use the preferences of the patient 
and the information available about the prognosis of the patient to guide the decision, as shown in 
Figure 2.1.
Some common pitfalls in EBM are the use of habits, rules and rituals of professionals (why is the 
evidence better than what I have done over the last 20 years?) and the often hierarchical structure 
in a medical setting. For example, the head of the department may lead decisions about treatment 
rather than the evidence. In addition, patients have become more informed and empowered over 
the years, which makes the role of the patients’ preferences more influential in decision making. 
One of the developments along this line is shared or collaborative decision making, a process in 
which clinicians and patients communicate together about the best available evidence to guide the 
treatment decision. In the field of neuropsychological rehabilitation we use, for example, client-
centred rehabilitation approaches in which collaborative goal setting among the treatment team, the 
individual with brain injury and their family is used (see too Chapter 45 in this volume, ‘Summary 
and guidelines for best practice’).
Best evidence on the basis of group studies
The RCT offers the best design to study the effectiveness of treatment. The reporting of RCTs can 
be improved by using well-accepted checklists, such as the Consolidated Standards of Reporting 
Trials (CONSORT) statement that was developed with the intention of facilitating the clear and 
transparent reporting of trials (CONSORT Statement, 2010). A recent review showed that journal 
endorsement of CONSORT may indeed benefit the completeness of trial reports (Turner et al., 
2012). Originally, the CONSORT statement was developed for use in pharmacological trials. In 
non-pharmacological treatment studies – such as those evaluating neuropsychological rehabilitation 
– it is not always possible to offer a sham intervention, and blinding of patients and professionals is 
also difficult. As a result, these RCTs could potentially be rated as having lower quality and therefore 
an alternative checklist for the report of non-pharmacological studies was developed. Specifically, 
the checklist to evaluate a report of a non-pharmacological trial (CLEAR-NPT) (Boutron et al., 
2005) is a more suitable tool to critically appraise RCTs in the field of neuropsychological 
rehabilitation.
Every year the number of peer-reviewed papers in the medical field is growing and it has become 
impossible for clinicians to gather the evidence themselves. Bjork, Roos and Lauri (2009) estimated 
that in 2006, 1.346 million articles were published in 23,750 journals. The average annual growth of 
the indexes in the Web of Sciences is estimated to be 2.5 per cent. One of the most efficient ways to 
translate this enormous amount of evidence into clinical practice is to use evidence-based guidelines. 
These are often published by professional societies (such as the Royal College of Physicians) or 
governmental organisations (such as the American Heart Association) or teams of researchers and 
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clinicians working together to formulate recommendations for clinical practice (such as the INCOG 
group). An example in the field of brain injury rehabilitation in adults are the sign guidelines from 
the Scottish Intercollegiate Guidelines Network (SIGN) (2013).
In the field of neuropsychological rehabilitation the INCOG recommendations for the 
management of cognition following traumatic brain injury can be used. An international group of 
researchers and clinicians (known as INCOG) convened to develop clinical practice guidelines for 
cognitive rehabilitation following traumatic brain injury. The INCOG group formulated 
recommendations on five topics: post-traumatic amnesia and delirium (Ponsford et al., 2014a), 
attention and information processing speed (Ponsford et al., 2014b), executive function and self-
awareness (Tate et al., 2014), cognitive communication (Togher et al., 2014) and memory (Velikonja 
et al., 2014).
The group led by Keith Cicerone formulated recommendations for cognitive rehabilitation after 
stroke and traumatic brain injury on the basis of a series of systematic reviews evaluating the 
effectiveness of cognitive rehabilitation (Cicerone et al., 2000, 2005, 2011). The results of these 
reviews have been translated into the cognitive rehabilitation manual published by the American 
Congress of Physical Medicine (Haskins, 2012).
Another way of gathering best evidence is by using information from the Cochrane Collaboration, 
which is a global independent network of researchers, professionals, patients, carers and people 
interested in gathering high-quality information to make health decisions. Results from systematic 
reviews are published in Cochrane Reviews, which can be accessed easily. For the field of 
neuropsychological rehabilitation, relevant reviews are available on many topics, for example: 
rehabilitation for memory deficits (Nair and Lincoln, 2007); attention deficits (Loetscher and 
Lincoln, 2013); executive dysfunction (Chung et al., 2013); spatial neglect (Bowen et al., 2013); 
perceptual disorders (Bowen et al., 2011); apraxia (West et al., 2008); aphasia (Brady et al., 2012); 
anxiety after stroke (Campbell Burton et al., 2011) and traumatic brain injury (Soo and Tate, 2007); 
and depression after stroke (Hackett et al., 2008) and after traumatic brain injury (Gertler, Tate and 
Cameron, 2015).
The evidence of intervention efficacy, which is summarised in meta-analyses and systematic 
reviews and translated into guidelines and recommendations for clinical practice, is mostly based on 
RCTs. However, implementing a treatment or replicating a study based on an RCT is not always 
possible because essential information in the reporting may be missing. First, it may not be possible 
to judge the reliability and validity of the trial findings, and second, information concerning the 
treatment itself may be missing. We recently reviewed 95 RCTs showing that there is a large body 
of evidence to support the efficacy of cognitive rehabilitation after brain injury, but we also concluded 
that most studies provided little information about the content of the actual treatment (van Heugten, 
Wolters-Gregorio and Wade, 2012). This makes it difficult to use the studies when making treatment 
decisions in daily clinical practice. In this paper, we suggested researchers and clinicians use a checklist 
when reporting rehabilitation interventions in future studies. Items in this checklist concern: 
(1) patient characteristics to help clinicians decide whether patients in the study are comparable to 
patients in their own setting; (2) treatment characteristics to help clinicians decide whether the 
treatment is applicable to their own setting; and (3) information on treatment goals, costs and benefits 
to enable clinicians to anticipate the outcomes.
Single case experimental design
SCED studies have a long tradition in education and psychology and are nowadays published in 
journals in the fields of special education, behavioural therapy, and neuropsychological rehabilitation 
(Evans et al., 2014). SCEDs have influenced clinical practice in some fields such as special education 
and intellectual disabilities, but in most medical settings RCTs, systematic reviews and meta-analyses 
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are valued as higher levels of evidence. SCEDs are classified under single case reports, despite the 
experimental basis and sometimes very high level of control for confounding factors.
The term SCED is used to describe studies in which one participant, or a series of participants, is 
studied in an experimental design in which the participant(s) act as their own control. Measurements 
are conducted repeatedly before the intervention (baseline phase), during the intervention 
(intervention phase) and possibly during a maintenance or treatment withdrawal phase. Confounding 
factors are controlled for in various ways. Many different designs are used, such as reversal designs 
(ABA or ABAB designs), multiple baseline designs and alternating or parallel treatment designs. 
Various names have been used to describe this type of study, including N-of-1 Trials (see Shadish 
and Sullivan, 2011). The power of the SCED relates to the number of measurements, rather than the 
number of participants as in group designs. The external validity of the SCED is increased when the 
design is replicated with more participants. SCEDs are different from case descriptions, case reports 
and pre-post designs where the design is mostly observational and outcomes are descriptive. A useful 
taxonomy of single case designs is given by Tate et al. (2013).
SCEDs are preferable when the patient population of interest shows high variability or cases are 
rare, which impedes the formation of homogeneous large-scale samples that are needed to conduct 
well-designed RCTs (Guyatt et al., 1990). For instance, this may be the case when studying people 
with brain injury with challenging behaviour such as aggression. The target behaviour may differ 
from patient to patient, which has consequences for the choice of a common outcome measure. An 
example of such specific target behaviour is a patient who frequently yelled, screamed and cursed, 
and threatened nurses during daily care (Winkens et al., 2014). Using a SCED this verbally aggressive 
behaviour was rated twice a day by a nurse immediately after activities of daily living (ADL) care, on 
a scale from 0 to 4: 0 = does not yell, scream or curse at all; 1 = yells, screams or curses once; 
2 = yells, screams or curses several times; 3 = yells, screams or curses a lot, and threatens nurse once 
or several times; 4 = continuous yelling, screaming, cursing or threatening behaviour.
Over the last few years, SCEDs have gained popularity. Evans et al. (2014) argued that this 
renewed interest is due to the following changes: SCEDs are now ranked as level 1 evidence by the 
Oxford Centre for EBM; tools for assessing the quality of SCEDs and guidelines for reporting the 
results of SCEDs are now available, such as the Risk of Bias in N-of-1 Trials (RoBiNT) scale (Tate 
et al., 2013); and the methods for analysing SCED data are improving and statistical analysis methods 
are becoming more available and accepted. The special issue on SCEDs in the journal Neuropsychological 
Rehabilitation (April 2014) is an example of the growing focus on SCEDs in the field of 
neuropsychological rehabilitation. (See too Chapter 43 ‘Avoiding bias in evaluating rehabilitation’ 
this volume.)
Economic evaluation
Economic evaluation can be defined as the comparative analysis of alternative courses of action in 
terms of costs on the one hand (resource use) and consequences on the other hand (outcomes, 
effects) (Adamiak, 2006). The aim of economic evaluation studies is to describe, measure and value 
all relevant alternative costs and consequences (e.g. intervention X versus comparator Y) (Shemilt 
et  al., 2011). Different types of economic evaluation exist, such as cost-benefit analysis, cost-
effectiveness analysis and cost-utility analysis. In partial economic evaluations (e.g. cost-analyses and 
cost-description studies), less evidence on the description, measurement or valuation of health-care 
interventions and technologies is provided in comparison to full economic evaluations. To give a 
relevant example of the difference between partial and full economic evaluations, we recently 
published a full economic evaluation of an augmented cognitive behavioural therapy intervention in 
comparison to computerised cognitive training for post-stroke depressive symptoms (Van Eeden 
et al., 2015). In this study both costs and effects were taken into account from a societal perspective. 
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A few years ago we published a cost-analysis of a residential community reintegration programme for 
severe brain injury patients where only the costs of the programme but not the effects were taken 
into account (van Heugten et al., 2011).
Economic evaluation research can be used in different areas of health care, regardless of the type 
of intervention, population or disease. However, there are certain types of intervention which are of 
specific interest to the field of economic evaluation research due to their potential for being cost-
effective for more than one population (e.g. self-management interventions). There is also a growing 
interest in chronic diseases because of their high social and financial burden. Acquired brain injury is 
universally acknowledged as a chronic disease because of the long-term consequences. Furthermore, 
the number of people living with the consequences of severe forms of brain injury is increasing as a 
result of improvements in acute medical care and population ageing. Therefore, the economic 
impact of these conditions, especially stroke and traumatic brain injury in young people, is becoming 
a topic of great interest for both researchers and health-care policy makers. This will probably lead 
to an increase in economic evaluation studies in the coming years. For more information on the 
cost-effectiveness of neuropsychological rehabilitation, see too Chapter 38, ‘The cost-effectiveness 
of neuropsychological rehabilitation’, this volume.
Evidence-based practice
As discussed in this chapter different forms of treatment evaluation are possible depending on the 
goal: does this treatment help my patient? Does this treatment work and for whom does it work? 
What are the costs and benefits of this treatment? Some requirements can be formulated for all forms 
of evaluation, regardless of the design. First, the level of functioning of the patient needs to be 
assessed at predetermined times, using the same instruments. Furthermore, measurements chosen to 
measure change in functioning should be aligned with the goals of treatment; for example, when the 
aim of treatment is return to work, it does not make sense to repeat a neuropsychological test. 
Finally, group studies typically report statistical significance on the basis of mean scores of the total 
group. In clinical practice mean scores are less relevant. Other forms of reporting results of studies on 
effectiveness should therefore also be considered. These forms may include the level of clinical 
relevance in addition to statistical significance by reporting, for instance, the percentage of patients 
that improved x points on the primary outcome measure. Other parameters can be reported in 
which individual improvements are taken into account, such as the Reliable Change Index (RCI). 
Finally, individualised outcome measures can be used on both a group and individual level. Goal 
Attainment Scaling is a valuable tool for this purpose and has been shown to be feasible in measuring 
outcome of rehabilitation after brain injury (Bouwens, van Heugten and Verhey, 2009). Client-
centred outcome measures can also form a valuable source of information when considering outcome 
from a more individual point of view. The Canadian Occupational Performance Measure (COPM) 
can, for instance, be used to define problems in occupational performance on the basis of a semi-
structured interview with the patient (Law et al., 1998). It can also assist in goal setting and measuring 
changes in performance over time from the patients’ perspective. Jenkinson, Ownsworth and Shum 
(2007) showed the clinical utility of the COPM in community-based rehabilitation of brain injured 
individuals and recommend incorporating self-ratings in the context of other outcomes.
It is important that health-care professionals are able to justify their treatment decisions on the 
basis of available evidence and in consideration of patient preferences and their patients’ status. 
Planning treatment explicitly and evaluating the outcome of treatment should therefore be a self-
evident process, either by monitoring the individual patient or applying the best available evidence 
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